<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36146672</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Interventions for Improving Long COVID-19 Symptomatology: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1863</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14091863</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Although the understanding of several aspects of long COVID-19 syndrome is increasing, there is limited literature regarding the treatment of these signs and symptoms. The aim of our systematic review was to understand which therapies have proved effective against the symptoms of long COVID-19.</AbstractText><AbstractText Label="METHODS">A systematic search for randomized controlled or clinical trials in several databases was conducted through 15 May 2022. Specific inclusion criteria included: (1) intervention studies, either randomized controlled (RCTs) or clinical trials; (2) diagnosis of long COVID-19, according to the World Health Organization criteria; (3) presence of long COVID-19 for at least 12 weeks after SARS-CoV-2 infection.</AbstractText><AbstractText Label="RESULTS">We initially found 1638 articles to screen. After removing 1602 works based on their title/abstract, we considered 35 full texts, and among them, two intervention studies were finally included. The first RCT focused on the greater improvement of treatment combining olfactory rehabilitation with oral supplementation with Palmitoylethanolamide and Luteolin in patients with olfactory dysfunction after COVID-19. The second study evaluated the positive impact of aromatherapy vs. standard care in adult females affected by fatigue.</AbstractText><AbstractText Label="CONCLUSION">Our systematic review found only two intervention studies focused on patients affected by long COVID-19. More intervention studies are needed to investigate potentially positive interventions for long COVID-19 symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Veronese</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9328-289X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatrics, University of Palermo Geriatric Unit, 90121 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonica</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatrics, University of Palermo Geriatric Unit, 90121 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotugno</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Human Oncology, Clinic of Infectious Diseases, University of Bari "Aldo Moro", 70121 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tulone</LastName><ForeName>Ottavia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatrics, University of Palermo Geriatric Unit, 90121 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camporeale</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Human Oncology, Clinic of Infectious Diseases, University of Bari "Aldo Moro", 70121 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Lee</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5340-9833</Identifier><AffiliationInfo><Affiliation>Centre for Health Performance and Wellbeing, Anglia Ruskin University, Cambridge CB1 1PT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trott</LastName><ForeName>Mike</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5978-3407</Identifier><AffiliationInfo><Affiliation>Centre for Public Health, Queen's University Belfast, Belfast BT7 1NN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruyere</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-4269-9393</Identifier><AffiliationInfo><Affiliation>WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Division of Public Health, Epidemiology and Health Economics, University of Li&#xe8;ge, 4000 Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirarchi</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatrics, University of Palermo Geriatric Unit, 90121 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatrics, University of Palermo Geriatric Unit, 90121 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bavaro</LastName><ForeName>Davide Fiore</ForeName><Initials>DF</Initials><Identifier Source="ORCID">0000-0002-4833-7118</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatrics, University of Palermo Geriatric Unit, 90121 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbagallo</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1349-6530</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatrics, University of Palermo Geriatric Unit, 90121 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dominguez</LastName><ForeName>Ligia J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatrics, University of Palermo Geriatric Unit, 90121 Palermo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marotta</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>General Directorate of Health Prevention, Ministry of Health, 00144 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silenzi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0652-0520</Identifier><AffiliationInfo><Affiliation>General Directorate of Health Prevention, Ministry of Health, 00144 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicastri</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5606-8712</Identifier><AffiliationInfo><Affiliation>National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Via Portuense, 292, 00149 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saracino</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Human Oncology, Clinic of Infectious Diseases, University of Bari "Aldo Moro", 70121 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Gennaro</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3453-5647</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Human Oncology, Clinic of Infectious Diseases, University of Bari "Aldo Moro", 70121 Bari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>KUX1ZNC9J2</RegistryNumber><NameOfSubstance UI="D047311">Luteolin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047311" MajorTopicYN="N">Luteolin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">interventions</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">therapy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36146672</ArticleId><ArticleId IdType="pmc">PMC9502379</ArticleId><ArticleId IdType="doi">10.3390/v14091863</ArticleId><ArticleId IdType="pii">v14091863</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F., Petrosillo N. New endemic and pandemic pathologies with interhuman airborne transmission through ear, nose and throat anatomical sites. Acta Otorhinolaryngol. Ital. 2022;42((Suppl. 1)):S5&#x2013;S13. doi: 10.14639/0392-100X-suppl.1-42-2022-01.</Citation><ArticleIdList><ArticleId IdType="doi">10.14639/0392-100X-suppl.1-42-2022-01</ArticleId><ArticleId IdType="pmc">PMC9137375</ArticleId><ArticleId IdType="pubmed">35763270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennon P., Crotty M., Fenton J.E. Infectious mononucleosis. BMJ. 2015;350:h1825. doi: 10.1136/bmj.h1825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h1825</ArticleId><ArticleId IdType="pubmed">25899165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.H., Shin H.-S., Park H.Y., Kim J.L., Lee J.J., Lee H., Won S.D., Han W. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in Middle East respiratory syndrome survivors. Psychiatry Investig. 2019;16:59. doi: 10.30773/pi.2018.10.22.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study. BMJ Open. 2021;11:e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dowds J., O&#x2019;Brien K., Sheill G., Dyer A.H., O&#x2019;Kelly B., Hynes J.P., Mooney A., Dunne J., Cheallaigh C.N., et al. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann. Am. Thorac. Soc. 2021;18:997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. How common is long COVID in children and adolescents? Pediatric Infect. Dis. J. 2021;40:e482. doi: 10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K., Montenegro-Jim&#xe9;nez Y., Torres-Castro R., Vera-Uribe R., Torralba Y., Alsina-Restoy X., Vasconcello-Castillo L., Villaro J. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Chronic Respir. Dis. 2021;18:14799731211002240. doi: 10.1177/14799731211002240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211002240</ArticleId><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Shamil H., Gary P., Haf D.E., Krishnarajar N., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V., Sohaei D., Diamandis E.P., Prassas I. COVID-19: From an acute to chronic disease? Potential long-term health consequences. Crit. Rev. Clin. Lab. Sci. 2021;58:297&#x2013;310. doi: 10.1080/10408363.2020.1860895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1860895</ArticleId><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley &amp; Sons; Hoboken, NJ, USA: 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkis-Onofre R., Catal&#xe1;-L&#xf3;pez F., Aromataris E., Lockwood C. How to properly use the PRISMA Statement. Syst. Rev. 2021;10:117. doi: 10.1186/s13643-021-01671-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01671-z</ArticleId><ArticleId IdType="pmc">PMC8056687</ArticleId><ArticleId IdType="pubmed">33875004</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. World Health Organization; Geneva, Switzerland: 2021.</Citation></Reference><Reference><Citation>Hawkins J., Hires C., Keenan L., Dunne E. Aromatherapy blend of thyme, orange, clove bud, and frankincense boosts energy levels in post-COVID-19 female patients: A randomized, double-blinded, placebo controlled clinical trial. Complement. Ther. Med. 2022;67:102823. doi: 10.1016/j.ctim.2022.102823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctim.2022.102823</ArticleId><ArticleId IdType="pmc">PMC8949693</ArticleId><ArticleId IdType="pubmed">35341944</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ascanio L., Vitelli F., Cingolani C., Maranzano M., Brenner M., Di Stadio A. Randomized clinical trial &#x201c;olfactory dysfunction after COVID-19: Olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin&#x201d;: Preliminary results. Eur. Rev. Med. Pharmacol. Sci. 2021;25:4156&#x2013;4162.</Citation><ArticleIdList><ArticleId IdType="pubmed">34156697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahra S.A., Iddawela S., Pillai K., Choudhury R.Y., Harky A. Can symptoms of anosmia and dysgeusia be diagnostic for COVID-19? Brain Behav. 2020;10:e01839. doi: 10.1002/brb3.1839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1839</ArticleId><ArticleId IdType="pmc">PMC7667367</ArticleId><ArticleId IdType="pubmed">32935915</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T., Sekinger B., Wolf S.R., Pauli E., Kobal G. &#x2018;Sniffin&#x2019; sticks&#x2019;: Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem. Senses. 1997;22:39&#x2013;52. doi: 10.1093/chemse/22.1.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/22.1.39</ArticleId><ArticleId IdType="pubmed">9056084</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., von Bartheld C.S. Anosmia in COVID-19: Underlying mechanisms and assessment of an olfactory route to brain infection. Neuroscientist. 2021;27:582&#x2013;603. doi: 10.1177/1073858420956905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420956905</ArticleId><ArticleId IdType="pmc">PMC7488171</ArticleId><ArticleId IdType="pubmed">32914699</ArticleId></ArticleIdList></Reference><Reference><Citation>Philpott C., Dixon J., Boak D. Qualitative Olfactory Disorders: Patient experiences and self-management. Allergy Rhinol. 2021;12:21526567211004251. doi: 10.1177/21526567211004251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21526567211004251</ArticleId><ArticleId IdType="pmc">PMC8474348</ArticleId><ArticleId IdType="pubmed">34589267</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker J.K., Kelly C.E., Smith B.C., Kirkwood A.F., Hopkins C., Gane S. Patients&#x2019; perspectives on qualitative olfactory dysfunction: Thematic analysis of social media posts. JMIR Form. Res. 2021;5:e29086. doi: 10.2196/29086.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/29086</ArticleId><ArticleId IdType="pmc">PMC8673716</ArticleId><ArticleId IdType="pubmed">34904953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon C.Y., Lee B. Complementary and integrative medicines for behavioral and psychological symptoms of dementia: Overview of systematic reviews. Explore. 2022 doi: 10.1016/j.explore.2022.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.explore.2022.08.005</ArticleId><ArticleId IdType="pubmed">35973932</ArticleId></ArticleIdList></Reference><Reference><Citation>Bested A.C., Marshall L.M. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An evidence-based approach to diagnosis and management by clinicians. Rev. Environ. Health. 2015;30:223&#x2013;249. doi: 10.1515/reveh-2015-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2015-0026</ArticleId><ArticleId IdType="pubmed">26613325</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow M.K.S., Kwek D.S.K., Ng A.W.K., Ong K.C., Kaw G.J.L., Lee L.S.U. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Clin. Endocrinol. 2005;63:197&#x2013;202. doi: 10.1111/j.1365-2265.2005.02325.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip K.E.J., Owles H., McVey S., Pagnuco T., Bruce K., Brunjes H., Banya W., Mollica J., Lound A., Zumpe S., et al. An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: A parallel-group, single-blind, randomised controlled trial. Lancet Respir. Med. 2022 doi: 10.1016/S2213-2600(22)00125-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00125-4</ArticleId><ArticleId IdType="pmc">PMC9045747</ArticleId><ArticleId IdType="pubmed">35489367</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Varnai R., Molnar T., Zavori L., T&#x151;k&#xe9;s-F&#xfc;zesi M., Illes Z., Kanizsai A., Csecsei P. Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms. Vaccines. 2022;10:165. doi: 10.3390/vaccines10020165.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020165</ArticleId><ArticleId IdType="pmc">PMC8924883</ArticleId><ArticleId IdType="pubmed">35214624</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F., Marotta C., Locantore P., Pizzol D., Putoto G. Malaria and COVID-19: Common and Different Findings. Trop. Med. Infect. Dis. 2020;5:141. doi: 10.3390/tropicalmed5030141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed5030141</ArticleId><ArticleId IdType="pmc">PMC7559940</ArticleId><ArticleId IdType="pubmed">32899935</ArticleId></ArticleIdList></Reference><Reference><Citation>Baronti A., Gentile F., Manetti A.C., Scatena A., Pellegrini S., Pucci A., Franzini M., Castiglione V., Maiese A., Giannoni A., et al. Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? Viruses. 2022;14:1644. doi: 10.3390/v14081644.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081644</ArticleId><ArticleId IdType="pmc">PMC9413746</ArticleId><ArticleId IdType="pubmed">36016266</ArticleId></ArticleIdList></Reference><Reference><Citation>Segala F.V., Bavaro D.F., Di Gennaro F., Salvati F., Marotta C., Saracino A., Murri R., Fantoni M. Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review. Viruses. 2021;13:2110. doi: 10.3390/v13112110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112110</ArticleId><ArticleId IdType="pmc">PMC8624326</ArticleId><ArticleId IdType="pubmed">34834917</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A., Baronti A., Manetti A.C., Di Paolo M., Turillazzi E., Frati P., Fineschi V. Death after the Administration of COVID-19 Vaccines Approved by EMA: Has a Causal Relationship Been Demonstrated? Vaccines. 2022;10:308. doi: 10.3390/vaccines10020308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020308</ArticleId><ArticleId IdType="pmc">PMC8875435</ArticleId><ArticleId IdType="pubmed">35214765</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid&#x2014;Mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022;43:268&#x2013;270. doi: 10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N., Smith L., Di Gennaro F., Bruy&#xe8;re O., Yang L., Demurtas J., Maggi S., Sabico S., Al-Daghri N.M., Barbagallo M., et al. Influenza Vaccination and COVID-19 Outcomes in People Older than 50 Years: Data from the Observational Longitudinal SHARE Study. Vaccines. 2022;10:899. doi: 10.3390/vaccines10060899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10060899</ArticleId><ArticleId IdType="pmc">PMC9229857</ArticleId><ArticleId IdType="pubmed">35746506</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F., Veronese N., Marotta C., Shin J.I., Koyanagi A., Silenzi A., Antunes M., Saracino A., Bavaro D.F., Soysal P., et al. Human Monkeypox: A Comprehensive Narrative Review and Analysis of the Public Health Implications. Microorganisms. 2022;10:1633. doi: 10.3390/microorganisms10081633.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10081633</ArticleId><ArticleId IdType="pmc">PMC9416167</ArticleId><ArticleId IdType="pubmed">36014051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane COVID-19 Study Register.  [(accessed on 15 May 2022)].  Available online:  https://covid19.cochrane.org/?q=k(Long%20and%20covid).k(%22long%20covid%22).c(study-types/interventional:Interventional).c(intervention-assignments/randomised:Randomised)&amp;pn=1.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>